TokenPost·

UroGen Expects Q4 Profitability as ZUSDURI Revenue Grows 35% Sequentially

Your call?

ZUSDURI produced $68 million in Q3 net product revenue, and repeat prescribers represented 50% of its writers.

Share

More news